Insider Transactions in Q4 2022 at Champions Oncology, Inc. (CSBR)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 19
2022
|
Joel Ackerman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+1.13%
|
$50,001
$3.21 P/Share
|
|
Oct 12
2022
|
Philip P. Breitfeld Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,562
-19.57%
|
$24,934
$7.51 P/Share
|
|
Oct 12
2022
|
Philip P. Breitfeld Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+31.41%
|
$24,999
$3.21 P/Share
|
|
Oct 12
2022
|
David Sidransky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,562
-0.46%
|
$24,934
$7.51 P/Share
|
|
Oct 12
2022
|
David Sidransky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+1.07%
|
$24,999
$3.21 P/Share
|
|
Oct 12
2022
|
Scott R Tobin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.0%
|
$30,000
$3.21 P/Share
|